RECOMBUMIN

Serial Number 79345867
Registration 7362015
700

Registration Progress

Application Filed
May 26, 2022
Under Examination
Approved for Publication
Feb 6, 2024
Published for Opposition
Feb 6, 2024
Registered
Apr 23, 2024

Trademark Image

RECOMBUMIN

Basic Information

Serial Number
79345867
Registration Number
7362015
Filing Date
May 26, 2022
Registration Date
April 23, 2024
Published for Opposition
February 6, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 23, 2024
Registration
Registered
Classes
001 005

Rights Holder

Sartorius Albumedix Limited

98
Address
HQ, Mabel Street
Nottingham NG2 3ED
GB

Ownership History

Albumedix Ltd

Original Applicant
99
GB

Albumedix Ltd

Owner at Publication
99
GB

Albumedix Ltd

Original Registrant
99
GB

Sartorius Albumedix Limited

New Owner After Registration #1
98
GB

Legal Representation

Attorney
Karen Lim

USPTO Deadlines

Next Deadline
1569 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20240423)
Due Date
April 23, 2030
Grace Period Ends
October 23, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

37 events
Date Code Type Description Documents
Apr 16, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 16, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 16, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 16, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 16, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Apr 11, 2025 ADCH M CHANGE OF NAME/ADDRESS REC'D FROM IB Loading...
Nov 9, 2024 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Oct 23, 2024 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Oct 23, 2024 FIMP P FINAL DISPOSITION PROCESSED Loading...
Jul 24, 2024 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Apr 23, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Apr 23, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Feb 6, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 6, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 5, 2024 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Jan 17, 2024 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Jan 17, 2024 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Jan 17, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 13, 2024 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Loading...
Dec 31, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 27, 2023 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Dec 27, 2023 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Loading...
Nov 3, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 3, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 3, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 23, 2023 RFNT P REFUSAL PROCESSED BY IB Loading...
May 3, 2023 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
May 3, 2023 RFRR P REFUSAL PROCESSED BY MPU Loading...
Apr 2, 2023 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Mar 16, 2023 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Mar 15, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 7, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 29, 2023 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Aug 2, 2022 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jul 29, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 27, 2022 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED Loading...
Jul 21, 2022 SDRC M SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB Loading...

Detailed Classifications

Class 001
Chemicals used in industry, science and for use in the manufacture of pharmaceuticals; chemical reagents other than for medical or veterinary purposes; diagnostic reagents and preparations, other than for medical or veterinary purposes; chemical excipients for use in the manufacture of pharmaceutical preparations; proteins for industrial purposes; recombinant human albumin for use as a stabilizer and excipient for industrial purposes and for use in the manufacture of cell culture media, cell and tissue storage and preservation media and for the manufacture of diagnostic imaging agents; cell culture reagents for scientific and research use, and chemical preservation reagents for scientific and research use; albumin for use in the manufacture of pharmaceutical products, vaccines, cellular therapies, regenerative medicines and gene therapies; protein in raw material form for scientific and medical research
Class 005
Pharmaceuticals for the treatment or prophylaxis of viral, bacterial, fungal, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, neurodegenerative, neuromuscular, central nervous system, gastrointestinal, hormonal, dermatological, psychiatric, immune system, urinary, angiogenic, genetic, menopausal, and pain related diseases and disorders; pharmaceutical products and substances for the treatment or prophylaxis of viral, bacterial, fungal, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, neurodegenerative, neuromuscular, central nervous system, gastrointestinal, hormonal, dermatological, psychiatric, immune system, urinary, angiogenic, genetic, menopausal, and pain related diseases and disorders; albumin, chemical preparations, synthetic peptides, protein supplements, monoclonal, polyclonal, immunological, native and recombinant antibodies for medical and veterinary use, cells for medical and veterinary use, viruses, live viruses, live- attenuated viruses, attenuated viruses, and virus-like particles and viral vectors for medical and veterinary use, vaccines, growth factors for medical and veterinary use, immune modulators for medical and veterinary use, monoclonal antibodies, biological tissue and tissue cultures, recombinant proteins for medical and veterinary use, nucleic acid sequences, blood plasma, blood components for medical and veterinary use, all being for pharmaceutical use for the treatment or prophylaxis of viral, bacterial, fungal, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, neurodegenerative, neuromuscular, central nervous system, gastrointestinal, hormonal, dermatological, psychiatric, immune system, urinary, angiogenic, genetic, menopausal, and pain related diseases and disorders; reagents for medical use; diagnostic reagents for medical use; protein supplements for pharmaceutical purposes; albuminous preparations for medical or veterinary purposes; recombinant albumin for biological therapeutic purposes

Classification

International Classes
001 005